Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor
Jaap Verweij(Erasmus MC Cancer Institute), Birthe Lund(Rigshospitalet), Jos H. Beijnen(Slotervaartziekenhuis), A. S. T. Planting(Erasmus MC Cancer Institute), M de Boer-Dennert(Erasmus MC Cancer Institute), I. Koier(European Organisation for Research and Treatment of Cancer), Hilde Rosing(Slotervaartziekenhuis), H. Hansen(Rigshospitalet)
Cited by 123Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis